Angiotensin II moderately decreases Plasmodium infection and experimental cerebral malaria in mice

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Gallego Delgado, Julio ^a   Baravian, Charlotte ^a   Edagha, Innocent ^a   Ty, Maureen C ^a   Ruiz Ortega, Marta ^b   Xu, Wenyue ^a,c   Rodriguez, Ana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; CAPTOPRIL; LOSARTAN; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; BLEEDING; BRAIN MALARIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; GROWTH INHIBITION; IMMUNE RESPONSE; INCIDENCE; MOUSE; NONHUMAN; PARASITEMIA; PATHOGENESIS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM GALLINACEUM; SURVIVAL TIME; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; HUMAN; MALARIA; MALARIA, CEREBRAL; PARASITOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALARIA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PARASITEMIA; PLASMODIUM BERGHEI; VASOCONSTRICTOR AGENTS;

EID: 84945573233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138191     Document Type: Article

References (21)

1. WHO. World Malaria Report. 2013.
2. Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet neurology. 2005; 4(12):827-40. doi: 10.1016/S1474-4422(05)70247-7 PMID: 16297841.
3. Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. The American journal of tropical medicine and hygiene. 1997; 57(4):389-98. PMID: 9347951.
4. Turner L, Lavstsen T, Berger SS, Wang CW, Petersen JE, Avril M, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013; 498(7455):502-5. doi: 10.1038/nature12216 PMID: 23739325; PubMed Central PMCID: PMC3870021.
5. Rasti N, Wahlgren M, Chen Q. Molecular aspects of malaria pathogenesis. FEMS immunology and medical microbiology. 2004; 41(1):9-26. doi: 10.1016/j.femsim.2004.01.010 PMID: 15094163.
6. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO molecular medicine. 2010; 2(7):247-57. doi: 10.1002/emmm.201000080 PMID: 20597104; PubMed Central PMCID: PMC3377325.
7. Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit M. Gene polymorphisms in angiotensin I converting enzyme (ACE I/D) and angiotensin II converting enzyme (ACE2 C->T) protect against cerebral malaria in Indian adults. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2010; 10(2):337-41. Epub 2010/02/02. doi: 10.1016/j.meegid. 2010.01.009 PMID: 20117248.
8. Saraiva VB, de Souza Silva L, Ferreira-Da Silva CT, da Silva-Filho JL, Teixeira-Ferreira A, Perales J, et al. Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides. PloS one. 2011; 6(2):e17174. Epub 2011/03/03. doi: 10.1371/journal.pone.0017174 PMID: 21364758; PubMed Central PMCID: PMC3041794.
9. Al-Merani SA, Brooks DP, Chapman BJ, Munday KA. The half-lives of angiotensin II, angiotensin IIamide, angiotensin III, Sar1-Ala8-angiotensin II and renin in the circulatory system of the rat. The Journal of physiology. 1978; 278:471-90. PMID: 671333; PubMed Central PMCID: PMC1282363.
10. Waknine-Grinberg JH, Hunt N, Bentura-Marciano A, McQuillan JA, Chan HW, Chan WC, et al. Artemisone effective against murine cerebral malaria. Malaria journal. 2010; 9:227. doi: 10.1186/1475-2875-9-227 PMID: 20691118; PubMed Central PMCID: PMC2928250.
11. Maciel C, de Oliveira Junior VX, Fazio MA, Nacif-Pimenta R, Miranda A, Pimenta PF, et al. Anti-plasmodium activity of angiotensin II and related synthetic peptides. PloS one. 2008; 3(9):e3296. doi: 10.1371/journal.pone.0003296 PMID: 18820728; PubMed Central PMCID: PMC2546444.
12. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010; 137(5):755-72. doi: 10.1017/S0031182009991715 PMID: 20028608.
13. Wang Y, Zhao S. Vascular Biology of the Placenta. Integrated Systems Physiology: from Molecules to Function to Disease. San Rafael (CA)2010.
14. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, et al. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. American journal of physiology Heart and circulatory physiology. 2009; 296(5):H1660-5. doi: 10.1152/ajpheart.00028.2009 PMID: 19252100; PubMed Central PMCID: PMC2685354.
15. Cassis LA, Huang J, Gong MC, Daugherty A. Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats. Regulatory peptides. 2004; 117 (2):107-16. PMID: 14700746.
16. Amani V, Boubou MI, Pied S, Marussig M, Walliker D, Mazier D, et al. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infection and immunity. 1998; 66(9):4093-9. PMID: 9712753; PubMed Central PMCID: PMC108491.
17. Silva-Filho JL, Souza MC, Ferreira-Dasilva CT, Silva LS, Costa MF, Padua TA, et al. Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection. PloS one. 2013; 8(4):e62999. doi: 10.1371/journal.pone.0062999 PMID: 23646169; PubMed Central PMCID: PMC3639972.
18. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nature medicine. 2006; 12 (12):1417-22. doi: 10.1038/nm1499 PMID: 17099710.
19. Faiz MA, Rahman MR, Hossain MA, Rashid HA. Cerebral malaria-a study of 104 cases. Bangladesh Medical Research Council bulletin. 1998; 24(2):35-42. PMID: 9926481.
20. Idro R, Karamagi C, Tumwine J. Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda. Annals of tropical paediatrics. 2004; 24(1):17-24. doi: 10.1179/027249304225013240 PMID: 15005962.
21. Jain V, Nagpal AC, Joel PK, Shukla M, Singh MP, Gupta RB, et al. Burden of cerebral malaria in central India (2004-2007). The American journal of tropical medicine and hygiene. 2008; 79(4):636-42. PMID: 18840756; PubMed Central PMCID: PMC2710578.